Folger Nolan Fleming Douglas Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.8M Buy
4,974
+20
+0.4% +$6.85K 0.15% 75
2026
Q1
$1.74M Sell
4,954
-20
-0.4% -$7.13K 0.16% 72
2025
Q4
$1.63M Hold
4,974
0.17% 70
2025
Q3
$1.4M Sell
4,974
-25
-0.5% -$7.25K 0.15% 74
2025
Q2
$1.4M Sell
4,999
-70
-1% -$19.8K 0.15% 73
2025
Q1
$1.58M Sell
5,069
-4
-0.1% -$1.18K 0.18% 70
2024
Q4
$1.32M Sell
5,073
-25
-0.5% -$7.42K 0.14% 76
2024
Q3
$1.64M Hold
5,098
0.16% 70
2024
Q2
$1.59M Buy
5,098
+44
+0.9% +$12.9K 0.16% 71
2024
Q1
$1.44M Hold
5,054
0.15% 72
2023
Q4
$1.46M Sell
5,054
-15
-0.3% -$4.09K 0.16% 72
2023
Q3
$1.36M Hold
5,069
0.16% 70
2023
Q2
$1.13M Buy
5,069
+123
+2% +$28.5K 0.12% 83
2023
Q1
$1.2M Hold
4,946
0.14% 80
2022
Q4
$1.3M Hold
4,946
0.16% 75
2022
Q3
$1.11M Hold
4,946
0.15% 76
2022
Q2
$1.2M Hold
4,946
0.16% 72
2022
Q1
$1.2M Hold
4,946
0.13% 85
2021
Q4
$1.11M Hold
4,946
0.12% 88
2021
Q3
$1.05M Hold
4,946
0.13% 90
2021
Q2
$1.21M Sell
4,946
-40
-0.8% -$9.84K 0.14% 81
2021
Q1
$1.24M Buy
4,986
+40
+0.8% +$9.54K 0.15% 80
2020
Q4
$1.14M Hold
4,946
0.15% 78
2020
Q3
$1.26M Hold
4,946
0.19% 68
2020
Q2
$1.17M Sell
4,946
-5
-0.1% -$1.14K 0.19% 70
2020
Q1
$1M Sell
4,951
-7
-0.1% -$1.53K 0.2% 69
2019
Q4
$1.2M Sell
4,958
-225
-4% -$49.6K 0.17% 72
2019
Q3
$1M Buy
5,183
+7
+0.1% +$1.34K 0.15% 76
2019
Q2
$954K Hold
5,176
0.14% 80
2019
Q1
$983K Hold
5,176
0.15% 74
2018
Q4
$1.01M Sell
5,176
-50
-1% -$9.76K 0.17% 71
2018
Q3
$1.08M Sell
5,226
-80
-2% -$15.8K 0.15% 74
2018
Q2
$980K Hold
5,306
0.14% 80
2018
Q1
$904K Sell
5,306
-25
-0.5% -$4.59K 0.13% 80
2017
Q4
$927K Buy
5,331
+780
+17% +$138K 0.13% 84
2017
Q3
$849K Hold
4,551
0.12% 84
2017
Q2
$784K Sell
4,551
-25
-0.5% -$4.07K 0.12% 87
2017
Q1
$751K Buy
4,576
+25
+0.5% +$4.15K 0.11% 89
2016
Q4
$783K Hold
4,551
0.13% 88
2016
Q3
$783K Hold
4,551
0.13% 88
2016
Q2
$693K Sell
4,551
-225
-5% -$35K 0.12% 92
2016
Q1
$716K Hold
4,776
0.13% 88
2015
Q4
$775K Hold
4,776
0.14% 90
2015
Q3
$660K Hold
4,776
0.14% 95
2015
Q2
$733K Hold
4,776
0.14% 91
2015
Q1
$764K Hold
4,776
0.13% 89
2014
Q4
$761K Sell
4,776
-25
-0.5% -$3.9K 0.13% 88
2014
Q3
$674K Sell
4,801
-840
-15% -$110K 0.12% 92
2014
Q2
$668K Buy
5,641
+1,316
+30% +$152K 0.12% 91
2014
Q1
$534K Sell
4,325
-6,400
-60% -$776K 0.11% 95
2013
Q4
$1.22M Sell
10,725
-35
-0.3% -$3.98K 0.21% 73
2013
Q3
$1.21M Hold
10,760
0.23% 71
2013
Q2
$1.06M Buy
+10,760
New +$1.12M 0.22% 67

Other funds holding AMGN

Folger Nolan Fleming Douglas Capital Management's AMGN Position: Q2 2026 in Review

Folger Nolan Fleming Douglas Capital Management increased its Amgen (AMGN) stake by 0.4% in Q2 2026, buying an estimated $6.85K and bringing the position to 4,974 shares worth $1.8M. The position accounts for 0.15% of the portfolio, ranked #75.

Folger Nolan Fleming Douglas Capital Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Folger Nolan Fleming Douglas Capital Management held 4,974 shares of Amgen worth $1.8M as of Q2 2026.
  • Folger Nolan Fleming Douglas Capital Management bought 20 Amgen shares in Q2 2026, an estimated $6.85K.
  • Amgen made up 0.15% of Folger Nolan Fleming Douglas Capital Management's portfolio in Q2 2026, its #75 holding.
  • Folger Nolan Fleming Douglas Capital Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Folger Nolan Fleming Douglas Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.